본문 바로가기
KERD
논문KCI 등재

수두 예방접종: 세계적인 현황과 우리나라 접종 스케줄에 대한 제안

Varicella vaccination: Worldwide status and p rovisional updated recommendation in Korea

최은화
대한소아감염학회 (The Korean Society of Pediatric Infectious Diseases)|2008.06|Pediatric Infection and Vaccine|제15권 제1호|pp. 11-18

1

조회

0

다운로드

3

인용

0

참고문헌

키워드

Varicella zoster virusOutbreakBreakthrough infectionVaricella vaccine

초록

Varicella is a highly infectious disease caused by the varicella zoster virus. The varicella vaccine was developed by Michiaki Takahashi in Japan in 1974. Despite the worldwide distribution of efficient vaccines, varicella vaccination policy is extremely variable from country to country. Although varicella vaccine is not currently recommended for universal vaccination in Japan, most countries throughout Europe, and developing countries, it had been introduced into Korea in 1988 and 20 years have elapsed since its use. Currently, varicella vaccine has been most extensively used in the United States where routine 2- dose vaccination program has been recently implemented for children. Recent 2-dose schedule in the United States and the availability of combination measles-rubella-varicella vaccines may lead to future varicella vaccination policy changes in many countries. With this background, this article summarizes the current status of varicella vaccination policies worldwide and presents provisional updated recommendation of varicella vaccination in Korea. (Korean J Pediatr Infect Dis 2008;15:11-18)

Abstract

Varicella is a highly infectious disease caused by the varicella zoster virus. The varicella vaccine was developed by Michiaki Takahashi in Japan in 1974. Despite the worldwide distribution of efficient vaccines, varicella vaccination policy is extremely variable from country to country. Although varicella vaccine is not currently recommended for universal vaccination in Japan, most countries throughout Europe, and developing countries, it had been introduced into Korea in 1988 and 20 years have elapsed since its use. Currently, varicella vaccine has been most extensively used in the United States where routine 2- dose vaccination program has been recently implemented for children. Recent 2-dose schedule in the United States and the availability of combination measles-rubella-varicella vaccines may lead to future varicella vaccination policy changes in many countries. With this background, this article summarizes the current status of varicella vaccination policies worldwide and presents provisional updated recommendation of varicella vaccination in Korea. (Korean J Pediatr Infect Dis 2008;15:11-18)

참고문헌 (35)

  1. Takahashi M, "Live vaccine used to prevent the spread of varicella in children in hospital", Lancet, 2, pp.1288~1290 (1974)
  2. Takahashi M, "Effectiveness of live varicella vaccine", Expert Opin Biol Ther, 4, pp.199~216 (2004)
  3. Kang JH, "The immunogenicity and safety study of 47 passaged Oka strain live attenuated varicella vaccine in healthy children", Korean J Pediatr Infect Dis, 5, pp.88~95 (1998)
  4. Kim DJ, "Epidemiology of varicella in Korea based on pediatricians office practice", J Korean Pediatr Soc, 40, pp.73~81 (1997)
  5. Sohn YM, "Immunogenicity and Safety of Live Attenuated Varicella Vaccine(MAV", 06 stratin) on Healthy Children and Immunocompromised Children, 1995, pp.38, 771~777
  6. Kim MR, "A Clinical and Epidemiologic Study on Varicella in Children", Korean J Pediatr Infect Dis, 5, pp.88~95 (1998)
  7. "Recommendations for the use of live attenuated varicella vaccine", Pediatrics, 95, pp.791~796 (1995)
  8. American Academy of Pediatrics, "Clinical report: Prevention of varicella: Recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule", Pediatrics, 120, pp.221~231 (2007)
  9. Centers for Disease Control and Prevention: Prevention of varicella, "Recommendations of the Advisory Committee on Immunization Practices(ACIP)", MMWR, 56(4), pp.1~40 (2007)
  10. Kuter BJ, "Oka", Merck varicella vaccine in healthy children: final report of a 2-year efficacy study and 7-year follow-up studies, 1991, pp.9, 643~647
  11. Nguyen HQ, "Decline in mortality due to varicella after implementation of varicella vaccination in the United States", N Engl J Med, 352, pp.450~458 (2005)
  12. Seward JF, "Varicella disease after introduction of varicella vaccine in the United States, 1995-2000", JAMA, 287, pp.606~611 (2002)
  13. Kuter B, "Ten year follow-up of healthy children who received one or two injections of varicella vaccine", Pediatr Infect Dis J, 23, pp.132~137 (2004)
  14. Clements DA, "Postlicensure study of varicella vaccine effectiveness in a day-care setting", Pediatr infect Dis J, 18, pp.1047~1050 (1999)
  15. Haddad MB, "Vaccine effectiveness during a varicella outbreak among schoolchildren: Utah, 20022003", Pediatrics, 115, pp.148893~ (2005)
  16. Galil K, "Outbreak of varicella at a daycare center despite vaccination", N Engl J Med, 347, pp.1909~1915 (2002)
  17. Lee BR, "An elementary school outbreak of varicella attributed to vaccine failure: policy implications", J Infect Dis, 190, pp.477~483 (2004)
  18. Verstraeten T, "Vaccine Safety Datalink Research Group. A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination", Pediatrics, 112, pp.e98~e103 (2003)
  19. Buchholz U, "Varicella outbreaks after vaccine licensure: should they make you chicken?", Pediatrics, 104, pp.561~563 (1999)
  20. Dworkin MS, "An outbreak of varicella among children attending preschool and elementary school in Illinois", Clin Infect Dis, 35, pp.102~104 (2002)
  21. Izurieta HS, "Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center", JAMA, 278, pp.1495~1499 (1997)
  22. Galil K, "Younger age at vaccination may increase risk of varicella vaccine failure", J Infect Dis, 186, pp.102~105 (2002)
  23. Centers for Disease Control and Prevention, "Varicella outbreak among vaccinated children Nebraska, 2004", MMWR, 55, pp.749~752 (2006)
  24. Chaves SS, "Loss of vaccine-induced immunity to varicella over time", N Engl J Med, 356, pp.1121~1129 (2007)
  25. Michalik DE, "Primary vaccine failure after 1 dose of varicella vaccine in healthy children", J Infect Dis, 197, pp.944~949 (2008)
  26. "전염병웹통계시스템"[URL]
  27. Sadzot-Delvaux C, "Varicella Vaccination in Japan, South Korea, and Europe", J Infect Dis, 197, pp.S185~S190 (2008)
  28. 이하경, "우리나라 6세 이하 소아의 예방접종률", 제57차 대한소아과 학회 추계학술대회, pp.90~ (2007)
  29. "Immunization, vaccines and biologicals:varicella vaccines"[URL]
  30. World Health Organization and Unicef, "Immunization Summary", ~
  31. Macartney KK, "Varicella Vaccination in Australia and New Zealand", J Infect Dis, 197, pp.S191~S195 (2008)
  32. Centers for Disease Control and Prevention, "Update:Recommendations from the Advisory Committee on Immunization Practices (ACIP) Regarding Administration of Combination MMRV Vaccine", MMWR, 57, pp.258~260 (2008)
  33. "Provisional updated ACIP recommendations for varicella vaccine use"[URL]
  34. Zhou F, "An Economic Analysis of the Universal Varicella Vaccination Program in the United States", J Infect Dis, 197, pp.S156~S164 (2008)
  35. Civen R, "Varicella outbreak epidemiology in an active surveillance site, 1995-2005", J Infect Dis, 197, pp.S114~S119 (2008)

이 간행물의 다른 논문 (9건)

2008년 대한소아과학회 예방접종 Schedule이환종pp. 1-4국내 로타바이러스 감염의 역학강진한pp. 5-10예방접종의 경제성 평가방법과 사례천병철pp. 19-28단일기관에서 조사한 소아 뇌농양의 임상양상(1997-2006)전진경, 이택진, 김기환, 김기주, 김동수pp. 29-34소아에서 안와와 안와주위 봉와직염에 관한 최근 7년간의 임상적 고찰이진, 박성신, 장진근, 최정호, 김은진, 차성호, 홍선영pp. 35-43
원문 보기